These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 16910099

  • 1. Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice.
    Noon A, Hunter RJ, Witte MH, Kriederman B, Bernas M, Rennels M, Percy D, Enerbäck S, Erickson RP.
    Lymphology; 2006 Jun; 39(2):84-94. PubMed ID: 16910099
    [Abstract] [Full Text] [Related]

  • 2. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.
    Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP, Glover TW.
    Hum Mol Genet; 2003 May 15; 12(10):1179-85. PubMed ID: 12719382
    [Abstract] [Full Text] [Related]

  • 3. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.
    Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S, Miura N, Alitalo K.
    Nat Med; 2004 Sep 15; 10(9):974-81. PubMed ID: 15322537
    [Abstract] [Full Text] [Related]

  • 4. Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene.
    Vreeburg M, Heitink MV, Damstra RJ, Moog U, van Geel M, van Steensel MA.
    Int J Dermatol; 2008 Nov 15; 47 Suppl 1():52-5. PubMed ID: 18986489
    [Abstract] [Full Text] [Related]

  • 5. Lymphedema-distichiasis syndrome without FOXC2 mutation: evidence for chromosome 16 duplication upstream of FOXC2.
    Witte MH, Erickson RP, Khalil M, Dellinger M, Bernas M, Grogan T, Nitta H, Feng J, Duggan D, Witte CL.
    Lymphology; 2009 Dec 15; 42(4):152-60. PubMed ID: 20218083
    [Abstract] [Full Text] [Related]

  • 6. Literature watch. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.
    Pepper MS.
    Lymphat Res Biol; 2003 Dec 15; 1(3):245-9. PubMed ID: 15624441
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel FOXC2 missense mutation identified in patient with lymphedema-distichiasis syndrome and review.
    Dellinger MT, Thome K, Bernas MJ, Erickson RP, Witte MH.
    Lymphology; 2008 Sep 15; 41(3):98-102. PubMed ID: 19013876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function.
    Tavian D, Missaglia S, Maltese PE, Michelini S, Fiorentino A, Ricci M, Serrani R, Walter MA, Bertelli M.
    Oncotarget; 2016 Aug 23; 7(34):54228-54239. PubMed ID: 27276711
    [Abstract] [Full Text] [Related]

  • 12. Transcription factor FOXC2 demarcates the jugular lymphangiogenic region in avian embryos.
    Rutscher K, Wilting J.
    Lymphology; 2008 Mar 23; 41(1):11-7. PubMed ID: 18581954
    [Abstract] [Full Text] [Related]

  • 13. Imbalance between Expression of FOXC2 and Its lncRNA in Lymphedema-Distichiasis Caused by Frameshift Mutations.
    Missaglia S, Tavian D, Michelini S, Maltese PE, Bonanomi A, Bertelli M.
    Genes (Basel); 2021 Apr 27; 12(5):. PubMed ID: 33925370
    [Abstract] [Full Text] [Related]

  • 14. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb.
    Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, Levick JR, Burnand KG, Mortimer PS, Lymphoedema Research Consortium.
    Circulation; 2007 Apr 10; 115(14):1912-20. PubMed ID: 17372167
    [Abstract] [Full Text] [Related]

  • 15. Lymphedema-distichiasis and FOXC2 gene mutations.
    Erickson RP.
    Lymphology; 2001 Mar 10; 34(1):1. PubMed ID: 11307659
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.
    Brice G, Mansour S, Bell R, Collin JR, Child AH, Brady AF, Sarfarazi M, Burnand KG, Jeffery S, Mortimer P, Murday VA.
    J Med Genet; 2002 Jul 10; 39(7):478-83. PubMed ID: 12114478
    [Abstract] [Full Text] [Related]

  • 17. Novel FOXC2 Mutation and Distichiasis in a Patient With Lymphedema-Distichiasis Syndrome.
    De Niear MA, Breazzano MP, Mawn LA.
    Ophthalmic Plast Reconstr Surg; 2018 Jul 10; 34(3):e88-e90. PubMed ID: 29406328
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic characterization of primary lymphedema.
    Connell F, Brice G, Mortimer P.
    Ann N Y Acad Sci; 2008 Jul 10; 1131():140-6. PubMed ID: 18519967
    [Abstract] [Full Text] [Related]

  • 19. FOXC2 Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and Cell Proliferation.
    Tavian D, Missaglia S, Michelini S, Maltese PE, Manara E, Mordente A, Bertelli M.
    Int J Mol Sci; 2020 Jul 20; 21(14):. PubMed ID: 32698337
    [Abstract] [Full Text] [Related]

  • 20. A Chinese pedigree of lymphoedema-distichiasis syndrome with a novel mutation in the FOXC2 gene.
    Zhu LL, Lv YN, Chen HD, Gao XH.
    Clin Exp Dermatol; 2014 Aug 20; 39(6):731-3. PubMed ID: 24984567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.